Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of FUS-Related ALS With Betamethasone - The TRANSLATE Study

NCT03707795 is registered in ClinicalTrials.gov with Edward Kasaraskis as lead sponsor.

NCT NCT03707795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03707795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of FUS-Related ALS With Betamethasone - The TRANSLATE Study
Lead sponsor
Edward Kasaraskis
Phase
Phase 1
Overall status
Completed
Start date
August 21, 2017
Completion date
January 10, 2019
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

familial amyotrophic lateral sclerosis